AskBorsa

Future Care for Medical Industries (FCMI)

FCMD
Fiscal year starts in January · currency EGP · latest: Q2 2026
Next results: Q3 2026 — expected around 19 January 2027estimated from earlier disclosure datesResults calendar ←
8.10EGP+1.89% today1w +15.7%1m +4.1%delayed · 3 November
Net profit · 2024
−19.73million
▼ 1451.7% vs 2023
Total assets · 2024
112million
▲ 7.8% vs 2023
Shareholders' equity · 2024
45.79million
▼ 25.0% vs 2023
Operating cash flow · 2024
21.24million
▲ 35.7% vs 2023

Key facts

Source: annual statements 2024
  • Future Care for Medical Industries (FCMI)'s net profit in 2024 was -19.73 million EGP, down 1451.7% from 1.46 million EGP in 2023.
  • Total assets at the end of 2024 were 112 million EGP, and shareholders' equity 45.79 million EGP.
  • Operating cash flow in 2024 was positive at 21.24 million EGP.

Future Care for Medical Industries (FCMI)'s Q3 2026 results are expected around 19 January — we email you the day they land

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

AI summary

Preparing a summary of the latest results…

Annual net profit last 5 years
Net profit
34.03thousand
−91.34thousand
919thousand
1.46million
−19.73million
20202021202220232024

Summarised financial statements

Excel · Pro
Swipe the table to see the other years.
Item · EGP20202021202220232024
Income statement
Net profit34.03 thousand-91.34 thousand919 thousand1.46 million-19.73 million
Gross profit1.15 million567 thousand2.78 million10.71 million18.85 million
Total assets34.99 million67.95 million64.99 million104 million112 million
Total liabilities8.62 million7.61 million4.3 million42.94 million66.31 million
Shareholders' equity26.38 million60.34 million60.68 million61.07 million45.79 million
Total liabilities and equity34.99 million67.95 million64.99 million104 million112 million
Operating cash flow-1.35 million-1.08 million-20.83 million15.66 million21.24 million
Investing cash flow—1.32 million-902 thousand-5.06 million-134 thousand
Financing cash flow890 thousand33.99 million-2.82 million-19.5 million-2.99 million
Net change in cash-461 thousand34.23 million-24.56 million-8.9 million8 million
Sign up free to see the full five years for every period.
Sign up free in seconds
With Google or your email, no password.

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. What does this line mean?

Results by period

One page per period: the figures against the same period a year earlier, and the official report.

Financial reports (2)

Other companies in Health Care & Pharmaceuticals

Ranked by latest annual net profit
All companies in the sector ←